MetLife Investment Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $654K | Buy |
|
|||||
|
2025
Q1 | $600K | Sell |
|
|||||
|
2024
Q4 | $883K | Buy |
|
|||||
|
2024
Q3 | $958K | Hold |
|
|||||
|
2024
Q2 | $887K | Buy |
|
|||||
|
2024
Q1 | $920K | Hold |
|
|||||
|
2023
Q4 | $1.2M | Hold |
|
|||||
|
2023
Q3 | $1.09M | Hold |
|
|||||
|
2023
Q2 | $540K | Buy |
|
|||||
|
2023
Q1 | $347K | Buy |
|
|||||
|
2022
Q4 | $384K | Hold |
|
|||||
|
2022
Q3 | $121K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $139K | Buy |
|
|||||
|
2021
Q4 | $41K | Sell |
|
|||||
|
2021
Q3 | $130K | Buy |
|
|||||
|
2021
Q2 | $44.5K | Sell |
|
|||||
|
2021
Q1 | $241K | Hold |
|
|||||
|
2020
Q4 | $693K | Hold |
|
|||||
|
2020
Q3 | $528K | Buy |
|
|||||
|
2020
Q2 | $230K | Buy |
|